You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase Ib, BRAF-mutated, BRAF V600E, BRAF V600D, BRAF V600K, colorectal cancer, colon cancer, rectal cancer, metastatic, BLRM with EWOC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • (no location specified)
Aug 18, 2022

Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • BRAF V600E Mutation Positive
  • Encorafenib Oral Capsule + Cetuximab
  • (no location specified)
Jan 30, 2023

Colorectal Cancer Metastatic Trial (Tunlametinib plus Vemurafenib, Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Tunlametinib plus Vemurafenib
  • Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy ± Cetuximab
  • (no location specified)
Aug 15, 2023

Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

Recruiting
  • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
  • +2 more
  • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
  • Chicago, Illinois
    Northwestern University
Nov 16, 2022

Cancer Trial (Dabrafenib, Trametinib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 25, 2023

Non-small-cell Lung Cancer Trial (HL-085+Vemurafenib)

Not yet recruiting
  • Non-small-cell Lung Cancer
  • (no location specified)
Jun 8, 2023

Non Small Cell Lung Cancer Trial (HLX208+HLX10)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • HLX208+HLX10
  • (no location specified)
Nov 30, 2022

Aspirin in Combination With Trametinib and Dabrafenib

Not yet recruiting
  • NSCLC
  • +4 more
  • Combind asprin with Trametinib and Dabrafenib
  • (no location specified)
Aug 4, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Colorectal Cancer Trial in Shanghai (VIC, Bevacizumab Plus Chemotherapy)

Recruiting
  • Colorectal Cancer
  • VIC
  • Bevacizumab Plus Chemotherapy
  • Shanghai, China
    Department of General Surgery, Zhongshan Hospital, Fudan Univers
Sep 14, 2022

BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)

Completed
  • BRAF V600E Unresectable or Metastatic Melanoma
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 9, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Terminated
  • Metastatic Colon Adenocarcinoma
  • +27 more
  • San Francisco, California
  • +1 more
Jan 5, 2023

Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,

Not yet recruiting
  • Colon Adenocarcinoma
  • +4 more
  • (no location specified)
Jan 24, 2023

NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

Not yet recruiting
  • NSCLC
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University
Sep 19, 2023

Metastatic Colorectal Cancer, mCRC Trial in Shenyang (HLX208)

Recruiting
  • Metastatic Colorectal Cancer
  • mCRC
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital
May 1, 2022

BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,

Recruiting
  • BRAF NP_004324.2:p.V600E
  • +2 more
  • Duarte, California
  • +1 more
Jan 19, 2023

BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer

Recruiting
  • Metastatic Non-small Cell Lung Cancer
  • BRAF V600 Mutation
    • Lyon, Rhône Alpes, France
      CHU Lyon - Hôpital Cardio-Vasculaire et Pneumologique Louis Prad
    Sep 14, 2022

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +3 more
    • Scottsdale, Arizona
    • +2 more
    Jan 4, 2023

    CRC Trial in Shanghai (HLX208, Cetuximab Injection [Erbitux])

    Recruiting
    • CRC
    • HLX208
    • Cetuximab Injection [Erbitux]
    • Shanghai, China
      Fudan University Affiliated Oncology Hospital
    Dec 30, 2021

    BRAF V600-mutated Lung Carcinoma Treated With Combination of

    Completed
    • Non Small Cell Lung Cancer
    • BRAF V600 Mutation
      • Créteil, France
      • +1 more
      Jun 29, 2022

      BRAF V600 Colorectal Cancer Trial in Worldwide (Dabrafenib, LTT462, Trametinib)

      Recruiting
      • BRAF V600 Colorectal Cancer
      • Los Angeles, California
      • +17 more
      Jun 7, 2022

      Cancer, BRAF V600 Mutation, Melanoma Trial (XP-102, Trametinib)

      Not yet recruiting
      • Cancer
      • +5 more
      • (no location specified)
      Aug 18, 2022

      BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

      Recruiting
      • BRAF NP_004324.2:p.V600M
      • +6 more
      • Portland, Oregon
        Providence Portland Medical Center
      Aug 17, 2022

      Solid Tumor Trial in Toronto (Binimetinib, Encorafenib)

      Recruiting
      • Solid Tumor
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Sep 23, 2022

      BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

      Active, not recruiting
      • BRAF NP_004324.2:p.V600X
      • +6 more
      • Cetuximab
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 22, 2022